Association of RNase L with a Ras GTPase-activating-like protein IQGAP1 in mediating the apoptosis of a human cancer cell-line

FEBS Journal

Volumn 277, Issue 21, 2010, Pages 4464-4473

  Sato, Akira ^a   Naito, Tomoharu ^a   Hiramoto, Akiko ^a   Goda, Kazato ^a   Omi, Takuya ^a   Kitade, Yukio ^b   Sasaki, Takuma ^c   Matsuda, Akira ^d   Fukushima, Masakazu ^a   Wataya, Yusuke ^a   Kim, Hye Sook ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Apoptosis; ECyd; Focused proteomics; IQGAP1; RNase L

Indexed keywords

3' ETHYNYLCYTIDINE; IMMUNOGLOBULIN G; IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; RIBONUCLEASE L; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; 1 (3 C ETHYNYLRIBOPENTOFURANOSYL)CYTOSINE; 1-(3-C-ETHYNYLRIBOPENTOFURANOSYL)CYTOSINE; CYTIDINE; DRUG DERIVATIVE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PPPA(2'P5'A)N DEPENDENT RIBONUCLEASE; PPPA(2'P5'A)N-DEPENDENT RIBONUCLEASE; RIBONUCLEASE;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; CELL SURVIVAL; DRUG EFFECT; GENETICS; METABOLISM; METHODOLOGY; NEOPLASM; NICK END LABELING; PATHOLOGY; PHOSPHORYLATION; PROTEIN BINDING; RNA INTERFERENCE; TUMOR CELL LINE; WESTERN BLOTTING;

MAMMALIA;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; CYTIDINE; ENDORIBONUCLEASES; HUMANS; IMMUNOPRECIPITATION; IN SITU NICK-END LABELING; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASMS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; RAS GTPASE-ACTIVATING PROTEINS; RNA INTERFERENCE;

EID: 79952108946     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07833.x     Document Type: Article

References (23)

1. Bisbal C & Silverman RH (2007) Diverse functions of RNase L and implications in pathology. Biochimie 89, 789-798. (Pubitemid 47008946)
2. Townsend HL, Jha BK, Han JQ, Maluf NK, Silverman RH & Barton DJ (2008) A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L. RNA 14, 1026-1036. (Pubitemid 351717484)
3. Castelli JC, Hassel BA, Wood KA, Li XL, Amemiya K, Dalakas MC, Torrence PF & Youle RJ (1997) A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J Exp Med 186, 967-972. (Pubitemid 27407357)
4. Díaz-Guerra M, Rivas C & Esteban M (1997) Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology 236, 354-363. (Pubitemid 27423778)
5. Zhou A, Paranjape J, Brown TL, Nie H, Naik S, Dong B, Chang A, Trapp B, Fairchild R, Colmenares C et al. (1997) Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase. EMBO J 16, 6355-6363. (Pubitemid 27483262)
6. Zhou A, Paranjape JM, Hassel BA, Nie H, Shah S, Galinski B & Silverman RH (1998) Impact of RNase L overexpression on viral and cellular growth and death. J Interferon Cytokine Res 18, 953-961. (Pubitemid 28565798)
7. Castelli JC, Hassel BA, Maran A, Paranjape J, Hewitt JA, Li XL, Hsu YT, Silverman RH & Youle RJ (1998) The role of 2′-5′-oligoadenylate- activated ribonuclease L in apoptosis. Cell Death Differ 5, 313-320.
8. Rusch L, Zhou A & Silverman RH (2000) Caspasedependent apoptosis by 2′,5′-oligoadenylate activation of RNase L is enhanced by IFN-beta. J Interferon Cytokine Res 18, 1091-1100. (Pubitemid 32015249)
9. Li G, Xiang Y, Sabapathy K & Silverman RH (2004) An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase. J Biol Chem 279, 1123-1131. (Pubitemid 38082634)
10. Hattori H, Tanaka M, Fukushima M, Sasaki T & Matsuda A (1996) Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl)- cytosine, 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity. J Med Chem 30, 5005-5011. (Pubitemid 26422516)
11. Takatori S, Tsutsumi S, Hidaka M, Kanda H, Matsuda A, Fukushima M & Wataya Y (1998) The characterization of cell death induced by 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl) cytosine (ECyd) in FM3A cells. Nucleosides Nucleotides 17, 1309-1317. (Pubitemid 28332282)
12. Takatori S, Kanda H, Takenaka K, Wataya Y, Matsuda A, Fukushima M, Shimamoto Y, Tanaka M & Sasaki T (1999) Antitumor mechanisms and metabolism of the novel antitumor nucleoside analogues, 1-(3-C-ethynyl-beta-d-ribo- pentofuranosyl) cytosine and 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl) uracil. Cancer Chemother Pharmacol 44, 97-104. (Pubitemid 29297054)
13. Naito T, Yokogawa T, Takatori S, Goda K, Hiramoto A, Sato A, Kitade Y, Sasaki T, Matsuda A, Fukushima M et al. (2009) Role of RNase L in apoptosis induced by 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl)cytosine. Cancer Chemother Pharmacol 63, 837-850.
14. Brown MD & Sacks DB (2006) IQGAP1 in cellular signaling: bridging the GAP. Trends Cell Biol 16, 242-249. (Pubitemid 43744436)
15. Johnson M, Sharma M & Henderson BR (2009) IQGAP1 regulation and roles in cancer. Cell Signal 21, 1471-1478.
16. White CD, Brown MD & Sacks DB (2009) IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis. FEBS Lett 583, 1817-1824.
17. Li Z, McNulty DE, Marler KJ, Lim L, Hall C, Annan RS & Sacks DB (2005) IQGAP1 promotes neurite outgrowth in a phosphorylation-dependent manner. J Biol Chem 280, 13871-13878. (Pubitemid 40517286)
18. Yoshimura A, Nakanishi M, Yatome C & Kitade Y (2002) Comparative study on the biological properties of 2′,5′-oligoadenylate derivatives with purified human RNase L expressed in E. coli. J Biochem 132, 643-648. (Pubitemid 35238919)
19. Lesiak K & Torrence PF (1986) Synthesis and biological activities of oligo(8-bromoadenylates) as analogues of 5′-O-triphosphoadenylyl(2′- 5′)adenylyl(2′-5′)adenosine. J Med Chem 29, 1015-1022. (Pubitemid 16068810)
20. Ueno Y, Naito T, Kawada K, Shibata A, Kim HS, Wataya Y & Kitade Y (2005) Synthesis of novel siRNAs having thymidine dimers consisting of a carbamate or a urea linkage at their 3′ overhang regions and their ability to suppress human RNase L protein expression. Biochem Biophys Res Commun 330, 1168-1175.
21. Ueno Y, Kawada K, Naito T, Shibata A, Yoshikawa K, Kim HS, Wataya Y & Kitade Y (2008) Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3′-termini. Bioorg Med Chem 16, 7698-7704.
22. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA & Struhl K (1999) Current Protocols in Molecular Biology, Vol. 2,Immunoprecipitation, Unit 10.16.1-10.16.29. John Wiley & Sons, Inc.
23. Sato A, Satake A, Hiramoto A, Wataya Y & Kim HS (2010) Protein expression profiles of necrosis and apoptosis induced by 5-fluoro-2′- deoxyuridine in mouse cancer cells. J Proteome Res 9, 2329-2338.